INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
SEC FORM 4/Option exerciseVerified data

Warrington Kenneth Howard Jr reported BSEM

Director · BioStem Technologies, Inc. · BioStem Technologies, Inc. — Restricted Stock Units

Side
M
Value
—
Shares
5,094
Price
—
Executed
Aug 27, 2026
Disclosed
Aug 28, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 27 executedAug 28, 2026 disclosed

BSEM · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BSEM

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    21
    UJ
    Ungrodt JodiDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    5,647 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    UJ
    Ungrodt JodiDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    5,647 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    SD
    Sonenreich Steven DDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    7,671 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    SD
    Sonenreich Steven DDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    7,671 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    13
    WH
    Warrington Kenneth Howard JrDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    5,094 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    LR
    Lesser Hannaway RaynaDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    7,671 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    LR
    Lesser Hannaway RaynaDirector
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    7,671 sh
    		Aug 27, 2026Aug 28, 2026
    traded Aug 27, 2026
    		+1dSEC FORM 4

    Evidence

    19
    FA
    Fortunato Michael AChief Accounting Officer
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    970 sh
    		Aug 9, 2026Aug 20, 2026
    traded Aug 9, 2026
    		+11dSEC FORM 4

    Evidence

    23
    FA
    Fortunato Michael AChief Accounting Officer
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    970 sh
    		Aug 9, 2026Aug 20, 2026
    traded Aug 9, 2026
    		+11dSEC FORM 4

    Evidence

    27
    PB
    Poe BrandonChief Financial Officer
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    10.6K sh
    		Aug 11, 2026Aug 20, 2026
    traded Aug 11, 2026
    		+9dSEC FORM 4

    Evidence

    31
    PB
    Poe BrandonChief Financial Officer
    BSEMBioStem Technologies, Inc.
    Option exercise
    		M—
    10.6K sh
    		Aug 11, 2026Aug 20, 2026
    traded Aug 11, 2026
    		+9dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002147208-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Aug 27, 2026
    Published
    Aug 28, 2026
    Ingested by INSIDER
    Nov 5, 02:20 UTC
    Last re-read
    Nov 5, 02:20 UTC

    Extracted facts

    Filer
    Warrington Kenneth Howard Jr
    Role
    Director
    Transaction
    Option exerciseAs filed: “M”
    Asset
    BioStem Technologies, Inc. — Restricted Stock Units
    Ticker
    BSEM
    Shares
    5,094
    Price per share
    $0
    Execution date (reported)
    Aug 27, 2026
    Owned after transaction
    0 shares
    Days from execution to publication
    1

    What this establishes

    Warrington Kenneth Howard Jr filed this Form 4 reporting a option exercise of BSEM on Aug 27, 2026. It became public on Aug 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Warrington Kenneth Howard Jrcik:0002147208
    Issuer
    BioStem Technologies, Inc.cik:0001658678

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.